SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as the community discusses its potential driven by partnerships and its QNX technology, particularly within the automotive sector. Some investors are focused on technical indicators, while others highlight the importance of upcoming earnings and news related to new deals, including expansion in Asia. There is a sense of anticipation for a breakout, with community members expressing strong conviction in the company's long-term prospects.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is trending as community members point to a constructive chart structure, accumulation, and overall strength. Discussions highlight the potential for a breakout as momentum and volume appear to be increasing. The community also seems excited about a potential "CBM" event.

Ucore Rare Metals, Inc. Is a technology company, which engages in the business of metal separation products, and services to the mining and mineral extraction industry. Its projects include Bokan-Dotson Ridge Rare Earth Element. The company was founded on October 5, 2006 and is headquartered in Halifax, Canada.

Ucore Rare Metals Inc

Ucore Rare Metals Inc.

Ucore Rare Metals is trending due to renewed interest in rare earth element processing, especially following news of China's tightening export restrictions on these critical materials and related technologies. The community is focused on Ucore's strategic positioning with its RapidSX technology and Louisiana Strategic Metals Complex, as a key player in establishing a North American supply chain independent of China. Additionally, the conditional approval from the Government of Canada for expansion is fueling optimism.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to its low float, leading to discussions of potential squeezes and comparisons to other high-momentum stocks like HKD and CURR. The community is actively watching for breakouts, particularly above the $15 mark, with some anticipating a run towards $20. Recent trading patterns and potential for high percentage gains are also fueling the interest.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors draw comparisons to Bloom Energy's recent gains, speculating that FCEL could follow a similar trajectory. The community is actively discussing potential partnerships and contracts, particularly in the context of increasing demand for AI data centers and growing interest in the company's carbon capture technology with ExxonMobil. Some investors are speculating that a deal related to AI data centers could cause a price surge.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending as investors focus on upcoming presentations at the AASLD Liver Meeting in November, anticipating potential partnership or buyout news. Community discussions revolve around the value of Belapectin, especially its combination with GLP-1 drugs, and the potential for a short squeeze due to high short interest as members debate potential buyout prices and the impact of upcoming presentations.

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Mining Inc

CIFR is trending due to anticipation surrounding its upcoming earnings report, with discussions focused on potential AI-related announcements and partnerships, including speculation about a deal with Google. Community members are actively debating potential price movements post-earnings and the impact of market manipulation, while also weighing the stock's positioning within the broader AI infrastructure and cryptocurrency mining sectors.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk's stock is trending amid community discussions around potential FDA decisions on its oral weight loss drug and concerns about government influence, particularly regarding the company's relationship with political figures. Investors are also focused on Novo's acquisition strategy, specifically its bidding war with Pfizer for Metsera, and the potential impact on the company's pipeline and shareholder value. Some traders express concern about the stock's recent performance.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

DGXX is trending as investors discuss its potential in the AI data center space, highlighting its partnerships and expansion plans. Community members are focused on breaking the $6 resistance level and anticipate further gains with upcoming tenant news and potential institutional investment. Comparisons to other companies in the sector and mentions of key investors are also fueling the conversation.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending amid discussions of a recent sharp decline apparently triggered by comments from an FDA official, raising concerns about market manipulation and potential conflicts of interest. While the official retracted the statement, the stock has struggled to recover, leading to frustration among investors and calls for a stronger response from the company's leadership. The community speculates on potential buyback programs, upcoming earnings, and the possibility of a buyout to restore investor confidence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VKTX That&#39;s what I was thinking too. Maybe NVO couldn&#39;t offer enough, they panicked quickly. Or someone else had deeper pockets and could offer more. NVO of course needs VKTX less than, say, ABBV, which means maybe they didn&#39;t want to outbid. In any case, very bullish.

The main thing here is we know NVO already offered something for MTSR this summer. It didn&#39;t work out. And a month after the PFE deal gets signed, NVO panicks and sends an unsolicited offer. 

Something happened between ~ Sept 20 and late October. What? We don&#39;t know yet, but I believe it involved VKTX...

Institutions probably had that same thought seeing as VKTX is up 10% today.

Rajesh

UkNic

GTL91

0wl2000

Rollercoaster22

Chicha

Jten10

John Morin

Alberto Lazzati

Ihavenoidea

my gut feeling $NVO tried $VKTX before going to $MTSR     Thay can’t ignore dual agonism and that  tirzepatide shattered their business.  
They have NN419 that just passed phase 1. But no data announcement makes me question  tolerability … just started odd design phase 2

StockTwits for iOS

Viking Therapeutics Inc

Metsera Inc

Biolover

 That's what I was thinking too. Maybe NVO couldn't offer enough, they panicked quickly. Or someone else had deeper pockets and could offer more. NVO of course needs VKTX less than, say, ABBV, which means maybe they didn't want to outbid. In any case, very bullish.

The main thing here is we know NVO already offered something for MTSR this summer. It didn't work out. And a month after the PFE deal gets signed, NVO panicks and sends an unsolicited offer. 

Something happened between ~ Sept 20 and late October. What? We don't know yet, but I believe it involved VKTX...

Institutions probably had that same thought seeing as VKTX is up 10% today.

Your favorite Viking investor.

@Bagholding_VKTX I Agree too. NVO´s bidding of Metsera only makes the chance of an Aquisition of VKTX much more atractive

StockTwits Web

 I Agree too. NVO´s bidding of Metsera only makes the chance of an Aquisition of VKTX much more atractive